Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 09 01:42PM ET
67.51
Dollar change
+0.77
Percentage change
1.16
%
Index- P/E40.65 EPS (ttm)1.66 Insider Own1.24% Shs Outstand190.55M Perf Week3.80%
Market Cap12.98B Forward P/E21.30 EPS next Y3.17 Insider Trans-0.25% Shs Float188.22M Perf Month0.85%
Income322.29M PEG2.03 EPS next Q0.55 Inst Own96.63% Short Float2.72% Perf Quarter-20.43%
Sales2.75B P/S4.73 EPS this Y158.37% Inst Trans-2.08% Short Ratio2.91 Perf Half Y-18.60%
Book/sh28.41 P/B2.38 EPS next Y40.97% ROA4.74% Short Interest5.12M Perf Year-28.89%
Cash/sh4.84 P/C13.95 EPS next 5Y20.00% ROE6.25% 52W Range61.15 - 99.56 Perf YTD-29.98%
Dividend Est.- P/FCF40.57 EPS past 5Y- ROI5.36% 52W High-32.19% Beta0.29
Dividend TTM- Quick Ratio2.62 Sales past 5Y10.23% Gross Margin77.12% 52W Low10.40% ATR (14)1.57
Dividend Ex-Date- Current Ratio4.27 EPS Y/Y TTM116.68% Oper. Margin14.23% RSI (14)55.80 Volatility3.05% 2.32%
Employees3401 Debt/Eq0.11 Sales Y/Y TTM19.99% Profit Margin11.73% Recom1.63 Target Price95.58
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q159.19% Payout0.00% Rel Volume0.65 Prev Close66.74
Sales Surprise6.01% EPS Surprise3.58% Sales Q/Q26.69% EarningsOct 29 AMC Avg Volume1.76M Price67.51
SMA203.95% SMA500.25% SMA200-15.42% Trades Volume764,888 Change1.16%
Date Action Analyst Rating Change Price Target Change
Nov-15-24Initiated Wolfe Research Outperform $95
Oct-30-24Downgrade William Blair Outperform → Mkt Perform
Oct-10-24Resumed Raymond James Outperform $79
Aug-20-24Upgrade Bernstein Mkt Perform → Outperform $94 → $110
May-17-24Downgrade Robert W. Baird Outperform → Neutral $104 → $72
May-14-24Initiated Evercore ISI Outperform $113
Nov-15-23Initiated Wells Fargo Overweight $100
Oct-23-23Upgrade Bernstein Underperform → Mkt Perform $82
Sep-28-23Initiated Raymond James Mkt Perform
Sep-18-23Initiated UBS Buy $120
Nov-28-24 11:31AM
Nov-27-24 09:20AM
Nov-21-24 05:26PM
09:40AM
Nov-20-24 09:45AM
06:54PM Loading…
Nov-19-24 06:54PM
Nov-16-24 10:45AM
Nov-12-24 08:30AM
Nov-07-24 09:35AM
Nov-06-24 08:00AM
Nov-05-24 09:40AM
Nov-04-24 12:45PM
12:00PM
09:45AM
Nov-01-24 01:12AM
07:33AM Loading…
Oct-31-24 07:33AM
Oct-30-24 12:14PM
10:19AM
03:13AM
Oct-29-24 06:30PM
05:20PM
04:20PM
04:03PM
Oct-24-24 07:00AM
06:32AM
Oct-22-24 10:01AM
Oct-17-24 09:45AM
Oct-16-24 08:30AM
Oct-04-24 10:04AM
Oct-01-24 12:45PM
09:35AM Loading…
09:35AM
Sep-30-24 07:03PM
07:03PM
09:45AM
Sep-25-24 03:50PM
Sep-21-24 09:55AM
Sep-18-24 08:00AM
Sep-17-24 11:15AM
07:18AM
Sep-16-24 06:45PM
04:01PM
03:12PM
Sep-13-24 09:45AM
Sep-08-24 02:03AM
Sep-04-24 01:30PM
01:00PM
11:30AM
07:30AM
Aug-29-24 11:53AM
09:50AM
08:15AM
08:00AM
04:12AM
Aug-28-24 12:45PM
09:45AM
Aug-23-24 07:56AM
Aug-21-24 08:30AM
07:00AM
Aug-19-24 09:00AM
Aug-13-24 10:34AM
09:50AM
Aug-12-24 12:45PM
Aug-09-24 09:15AM
Aug-06-24 02:42PM
01:35PM
11:51AM
10:35AM
07:45AM
Aug-05-24 06:00PM
05:15PM
04:15PM
04:03PM
04:01PM
Jul-31-24 09:15AM
Jul-25-24 06:33AM
Jul-24-24 04:05PM
12:10PM
Jul-23-24 08:00AM
Jul-22-24 10:01AM
Jul-15-24 08:41AM
Jul-01-24 09:20AM
Jun-20-24 03:18AM
Jun-17-24 08:30AM
Jun-11-24 10:57AM
Jun-07-24 06:09PM
09:00AM
Jun-05-24 06:14AM
Jun-04-24 08:00AM
May-25-24 11:10PM
May-24-24 11:31AM
May-18-24 05:06AM
May-15-24 07:00AM
May-13-24 04:14PM
May-09-24 06:15AM
May-08-24 08:00AM
May-06-24 07:00PM
04:47PM
May-04-24 04:00PM
May-03-24 02:31PM
Apr-29-24 02:26PM
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Guyer Charles GregEVP, Chief Technical OfficerNov 12 '24Sale66.375,278350,32468,909Nov 14 02:44 PM
Guyer Charles GregOfficerNov 12 '24Proposed Sale66.375,278350,324Nov 12 02:27 PM
Burkhart ErinGVP, Chief Accounting OfficerAug 13 '24Sale90.0071464,26014,449Aug 15 03:57 PM
Burkhart ErinOfficerAug 13 '24Proposed Sale90.0071464,260Aug 13 11:48 AM
HERON ELAINE JDirectorJun 03 '24Option Exercise63.105,047318,466101,888Jun 04 07:29 PM
MEIER RICHARD ADirectorJun 03 '24Option Exercise63.106,600416,460126,227Jun 04 07:28 PM
Mueller BrianEVP, Chief Financial OfficerMay 30 '24Option Exercise63.105,000315,50077,159May 31 06:28 PM
Mueller BrianEVP, Chief Financial OfficerMay 30 '24Sale75.195,000375,95072,159May 31 06:28 PM
Davis George EricEVP, Chief Legal OfficerMay 28 '24Option Exercise63.1040,8502,577,63597,007May 30 06:18 PM
Davis George EricEVP, Chief Legal OfficerMay 28 '24Sale74.5140,8503,043,80256,157May 30 06:18 PM
BIENAIME JEAN JACQUESDirectorMay 09 '24Option Exercise63.1020,0001,262,000494,994May 13 03:57 PM
BIENAIME JEAN JACQUESDirectorMay 10 '24Option Exercise63.1020,0001,262,000494,994May 13 03:57 PM
BIENAIME JEAN JACQUESDirectorMay 09 '24Sale81.6220,0001,632,400474,994May 13 03:57 PM
BIENAIME JEAN JACQUESDirectorMay 10 '24Sale81.1420,0001,622,800474,994May 13 03:57 PM
Davis George EricEVP, Chief Legal OfficerMay 02 '24Option Exercise63.101,850116,73558,007May 06 04:45 PM
Davis George EricEVP, Chief Legal OfficerMay 02 '24Sale85.011,850157,26856,157May 06 04:45 PM
Ajer Jeffrey RobertEVP, Chief Commercial OfficerMay 02 '24Sale82.915,000414,55066,767May 06 04:40 PM
BIENAIME JEAN JACQUESDirectorApr 11 '24Option Exercise63.1020,0001,262,000494,994Apr 15 04:21 PM
BIENAIME JEAN JACQUESDirectorApr 12 '24Option Exercise63.1020,0001,262,000494,994Apr 15 04:21 PM
BIENAIME JEAN JACQUESDirectorApr 12 '24Sale91.2620,0001,825,200474,994Apr 15 04:21 PM
BIENAIME JEAN JACQUESDirectorApr 11 '24Sale90.9920,0001,819,800474,994Apr 15 04:21 PM
Burkhart ErinGVP, Chief Accounting OfficerApr 10 '24Sale90.002,286205,74016,156Apr 12 03:07 PM
Davis George EricEVP, Chief Legal OfficerMar 28 '24Sale88.3424,6022,173,34155,856Apr 01 04:54 PM
Slamon DennisDirectorMar 18 '24Option Exercise79.7010,000797,00040,809Mar 20 05:13 PM
FUCHS HENRY JPresident, Worldwide R&DMar 05 '24Sale85.1835,3413,010,396212,117Mar 07 06:54 PM
BIENAIME JEAN JACQUESDirectorMar 06 '24Sale86.711,00086,713560,203Mar 07 05:35 PM
BIENAIME JEAN JACQUESDirectorMar 05 '24Sale85.511,00085,510561,203Mar 07 05:35 PM
Ajer Jeffrey RobertEVP, Chief Commercial OfficerMar 05 '24Sale87.074,000348,28094,047Mar 07 05:32 PM
BIENAIME JEAN JACQUESDirectorFeb 27 '24Sale90.351,00090,350562,203Feb 29 05:05 PM
BIENAIME JEAN JACQUESDirectorFeb 08 '24Option Exercise63.1015,000946,500434,602Feb 12 05:20 PM
BIENAIME JEAN JACQUESDirectorFeb 09 '24Option Exercise63.1015,000946,500434,602Feb 12 05:20 PM
BIENAIME JEAN JACQUESDirectorFeb 08 '24Sale89.7715,0001,346,550419,602Feb 12 05:20 PM
BIENAIME JEAN JACQUESDirectorFeb 09 '24Sale88.2815,0001,324,200419,602Feb 12 05:20 PM
BIENAIME JEAN JACQUESDirectorJan 09 '24Option Exercise63.1010,000631,000435,162Jan 11 02:40 PM
BIENAIME JEAN JACQUESDirectorJan 10 '24Option Exercise63.1010,000631,000435,162Jan 11 02:40 PM
BIENAIME JEAN JACQUESDirectorJan 09 '24Sale98.1910,000981,900425,162Jan 11 02:40 PM
BIENAIME JEAN JACQUESDirectorJan 10 '24Sale96.3810,000963,800425,162Jan 11 02:40 PM
BIENAIME JEAN JACQUESDirectorDec 21 '23Option Exercise63.1010,000631,000435,112Dec 22 05:14 PM
BIENAIME JEAN JACQUESDirectorDec 21 '23Sale93.9910,000939,900425,112Dec 22 05:14 PM
Davis George EricEVP, Chief Legal OfficerDec 13 '23Sale95.3013,7641,311,70955,710Dec 14 06:18 PM